Jacobson, M. A.; Besch, C. L.; Child, C.; Hafner, R.; Muth, K.; Deyton, L. (1991). "Clinical programs for clinical research on AIDS: Description of a randomized prospective study of clindamycin versus pyrimethamine for prevention of Toxoplasma gondii infection". European Journal of Clinical Microbiology & Infectious Diseases. 10 (3): 195–198. doi:10.1007/BF01964462. PMID1676364. S2CID8673486.
MacArthur, RD; Chen, L; Mayers, DL; Besch, CL; Novak, R; van den Berg-Wolf, M; Yurik, T; Peng, G; Schmetter, B; Brizz, B; Abrams, D (April 2001). "The rationale and design of the CPCRA (Terry Beirn Community Programs for Clinical Research on AIDS) 058 FIRST (Flexible Initial Retrovirus Suppressive Therapies) trial". Control Clin Trials. 22 (2): 176–90. doi:10.1016/S0197-2456(01)00111-8. PMID11306155.
Jacobson, M. A.; Besch, C. L.; Child, C.; Hafner, R.; Muth, K.; Deyton, L. (1991). "Clinical programs for clinical research on AIDS: Description of a randomized prospective study of clindamycin versus pyrimethamine for prevention of Toxoplasma gondii infection". European Journal of Clinical Microbiology & Infectious Diseases. 10 (3): 195–198. doi:10.1007/BF01964462. PMID1676364. S2CID8673486.
MacArthur, RD; Chen, L; Mayers, DL; Besch, CL; Novak, R; van den Berg-Wolf, M; Yurik, T; Peng, G; Schmetter, B; Brizz, B; Abrams, D (April 2001). "The rationale and design of the CPCRA (Terry Beirn Community Programs for Clinical Research on AIDS) 058 FIRST (Flexible Initial Retrovirus Suppressive Therapies) trial". Control Clin Trials. 22 (2): 176–90. doi:10.1016/S0197-2456(01)00111-8. PMID11306155.
aidsinfo.nih.gov
"NIAID Research on AIDS" (Press release). aidsinfo.nih.gov. 1 January 1995. Retrieved 22 April 2016.
Jacobson, M. A.; Besch, C. L.; Child, C.; Hafner, R.; Muth, K.; Deyton, L. (1991). "Clinical programs for clinical research on AIDS: Description of a randomized prospective study of clindamycin versus pyrimethamine for prevention of Toxoplasma gondii infection". European Journal of Clinical Microbiology & Infectious Diseases. 10 (3): 195–198. doi:10.1007/BF01964462. PMID1676364. S2CID8673486.